Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) price on Friday, May 02, rose 0.33% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $64.01.
A look at the stock’s price movement, the close in the last trading session was $63.80, moving within a range at $63.89 and $66.04. The beta value (5-Year monthly) was 2.324. Turning to its 52-week performance, $68.58 and $35.17 were the 52-week high and 52-week low respectively. Overall, RYTM moved 23.19% over the past month.
Rhythm Pharmaceuticals Inc’s market cap currently stands at around $4.07 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-25.
Turning to the stock’s technical picture we see that short term indicators suggest on average that RYTM is a 100% Buy. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 5 recommend RYTM as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
RYTM’s current price about 5.67% and 14.85% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 61.82, while 7-day volatility ratio is 3.22% and 6.44% in the 30-day chart. Further, Rhythm Pharmaceuticals Inc (RYTM) has a beta value of 2.40, and an average true range (ATR) of 3.02. Analysts have given the company’s stock an average 52-week price target of $70, forecast between a low of $64 and high of $80. Looking at the price targets, the low is 0.02% off current price level while to achieve the yearly target high, price needs to move -24.98%. Nonetheless, investors will most likely welcome a -9.36% jump to $70 which is the analysts’ median price.
If we refocus on Rhythm Pharmaceuticals Inc (NASDAQ:RYTM), historical trading data shows that trading volumes averaged 0.66 over the past 10 days and 673.30K over the past 3 months. The company’s latest data on shares outstanding shows there are 62.39 million shares.
The 9.97% of Rhythm Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 94.76% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 5.11 million on 2025-04-15, giving us a short ratio of 5.7. The data shows that as of 2025-04-15 short interest in Rhythm Pharmaceuticals Inc (RYTM) stood at 1204.0 of shares outstanding, with shares short rising to 4.71 million registered in 2025-03-14. Current price change has pushed the stock 14.34% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the RYTM stock continues to rise going into the next quarter.
